SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: drdan who wrote (1012)	6/17/1998 1:31:00 PM
From: Gwolf	Read Replies (2) of 5402

You can see why I only used the figure of 10% of the market equaling $95 per share in revenues instead of the higher $952. At the moment SGNC does look to be able to capture the entire market. Figuring 10% is extremely conservative and would assume that some other major competitor or series of competitors gathers the other 90% of the market. Look at how may potential competitors there are right now. If you really stretched your imagination you might say that 1 or 2 could have a slight chance given enough time. If you look at Dr.Drees theory about the rejection problems of recycle Human blood or cow's blood then you come back to PHER-02 as the only viable solution to this market. My assumption was using a $20 billion dollar market which has been publicly stated as the total market minus actual human donors. I encourage investors to read the Due Diligence material posted on the "information thread", call Dr. Drees and then work through the numbers. Do your own homework DO NOT DEPEND ON ANYONE ELSE. Each investor should know why they are buying this stock for themselves. Gwolf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next